Schizophrenia researchers may ask themselves—or be asked by others—whether their research is relevant in the face of the COVID-19 pandemic. This commentary argues that schizophrenia research is more relevant than ever during this public health crisis, because of the likelihood that the COVID-19 pandemic may lead to increased incidence of psychotic disorders.
Is schizophrenia research relevant during the COVID-19 pandemic?